Core Points - The company has successfully completed a non-public offering of 69,098,949 shares at a price of RMB 36.18 per share, raising a total of approximately RMB 2.5 billion, with a net amount of approximately RMB 2.49 billion after deducting issuance costs [1][2] - The company has changed the use of remaining funds from the terminated new energy intelligent fracturing equipment project to oil and gas technology service projects, with a remaining balance of RMB 758.205 million as of November 30, 2023 [2][3] - The company has established special accounts for the management of raised funds and signed tripartite supervision agreements with banks and the sponsor [4][7] Fund Management - The company has opened special accounts for the raised funds at Huaxia Bank and Zheshang Bank, with both accounts currently having a balance of RMB 0.00 [6][8] - The tripartite supervision agreements stipulate that the funds in these accounts are exclusively for the digital transformation phase one project and oil and gas technology service projects, prohibiting any other use [9][10] - The agreements include provisions for regular audits and reporting, with the sponsor having the right to supervise the use of funds and requiring monthly statements from the banks [11][12] Project Timeline - The company has postponed the expected operational date for the digital transformation phase one project and oil and gas technology service projects to December 31, 2027, without changing the investment amounts or project entities [3][4]

Summary of Key Points Core Viewpoint - Suzhou Ruikeda Connection System Co., Ltd. has successfully issued convertible bonds amounting to RMB 1 billion, with a net amount of RMB 988.85 million after deducting issuance costs, and has established a special account for the management of these funds [2][3][4]. Group 1: Fundraising Details - The company issued 10 million convertible bonds with a face value of RMB 100 each, for a total of RMB 1 billion, with a maturity of 6 years [2]. - The actual net amount raised after deducting issuance costs of RMB 11.15 million is RMB 988.85 million, which was verified by a certified public accountant [2]. Group 2: Special Account and Agreement - The company has opened a special account for the management of the raised funds, authorized by the board of directors, to ensure proper storage and usage of the funds [3][4]. - A tripartite supervision agreement has been signed among the company, the underwriter Dongwu Securities, and the banks holding the funds to regulate the management and usage of the raised funds [4][5]. Group 3: Key Provisions of the Tripartite Agreement - The special account is exclusively for the storage and use of funds raised from the convertible bond issuance, specifically for designated projects [6][12]. - The underwriter is responsible for supervising the usage of the funds and must conduct semi-annual inspections of the fund management [8][13]. - Any withdrawal exceeding 20% of the net amount raised must be reported to the underwriter, ensuring transparency in fund usage [9][22].

登录新浪财经APP 搜索【信披】查看更多考评等级 关于未能按期归还暂时补充流动资金的闲置 募集资金的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要事项： ● 根据前期临时债委会协议，公司需在最长不超过6个月内，即2025年11月8日前完成24,000万元前期暂 时补流的募集资金归还，如未能按时归还，临时债委会将表决继续存续或就地解散。截至本公告披露 日，临时债委会前期约定的期限已满，公司尚未将该笔24,000万元暂时补充流动资金的闲置募集资金归 还至募集资金专用账户。 ● 近日，临时债委会召开了临时债委会工作会议，各债权行于会议中现场表决，同意临时债委会继续存 续。本次临时债委会延续6个月，自2025年11月8日至2026年5月7日。截至目前，《临时债委会协议》补 充协议尚未正式签署完毕，具体以最终签署的补充协议为准。敬请广大投资者注意投资风险。 一、未能按期归还暂时补充流动资金的闲置募集资金事项概述 苏州瀚川智能科技股份有限公司（以下简称"公司"或"瀚川智能"）于2023年1月9日收到中国证券监督管 理委 ...

Fundraising Overview - The company successfully completed its initial public offering (IPO) by issuing 17,543,860 shares at a price of RMB 106.19 per share, raising a total of RMB 186,298.25 million, with a net amount of RMB 174,219.58 million after deducting issuance costs [2][3] Fund Management and Usage - The company has established a special account for the raised funds, which is solely designated for the R&D center construction project and other related projects, ensuring that the funds are not used for any other purposes [6][20] - The balance in the special account as of November 11, 2025, is RMB 31,244.82 million, with additional accounts holding balances of RMB 8,000 million and RMB 9,972.27 million [11][15][20] Regulatory Compliance - The company has signed a tripartite supervision agreement with its wholly-owned subsidiary and the underwriting institution to ensure compliance with relevant laws and regulations, protecting investors' rights [4][26] - The underwriting institution is responsible for ongoing supervision of the fund usage, including conducting on-site investigations and providing regular account statements [7][27] Changes in Project Implementation - The company has approved changes to the implementation location of the R&D center project and has authorized the use of part of the raised funds for capital increase in its wholly-owned subsidiary to facilitate the project [3][30]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001400 证券简称：江顺科技 公告编号：2025-047 江苏江顺精密科技集团股份有限公司 关于新增募集资金专户并签订募集资金监管协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意江苏江顺精密科技集团股份有限公司首次公开发行股票注册的批 复》（证监许可〔2025〕608号）同意注册，并经深圳证券交易所《关于江苏江顺精密科技集团股份有 限公司人民币普通股股票上市的通知》（深证上〔2025〕364号）同意，江苏江顺精密科技集团股份有 限公司（以下简称"公司"）已向社会公众公开发行人民币普通股（A股）股票1,500万股，发行价格为每 股人民币37.36元，募集资金总额为人民币560,400,000.00元，扣除与发行有关的费用人民币 69,930,292.50元（不含增值税）后，实际募集资金净额为490,469,707.50元。 截至2025年4月21日，公司上述募集资金净额已全部到位，立信中联会计师事务所（特殊普通合伙）对 本次发行募集 ...

Group 1 - The core point of the announcement is the completion of the fundraising project and the decision to permanently supplement working capital with the surplus funds amounting to 51.41 million yuan [2][6][9] - The surplus funds include interest income of 8.598 million yuan, and the total surplus is based on the balance in the special account on the day of transfer [2][4] - The decision to use surplus funds for working capital is aimed at improving operational efficiency and supporting business development, aligning with the company's long-term strategy [6][9][10] Group 2 - The fundraising project was approved by the board and the supervisory committee on November 24, 2025, and does not require shareholder meeting approval due to the surplus being less than 10% of the net fundraising amount [7][30] - The company will close the special fundraising account after transferring the surplus funds to a general bank account [6][10] - The decision to permanently supplement working capital is considered a reasonable decision based on the project's implementation and the company's operational situation, ensuring no harm to the interests of the company and its shareholders [6][10] Group 3 - The company has also announced a capital increase for its subsidiary, Xi'an Ruikong, with an investment of 20 million yuan from Yingyuan Shuangyin and 5 million yuan from Shaanxi Supply and Marketing [13][16] - The company's shareholding in Xi'an Ruikong will decrease from 35.70% to 32.13%, but it will remain a consolidated subsidiary [13][23] - The decision to waive the right of first refusal for the capital increase is based on strategic planning and does not harm the interests of shareholders [13][23]

Core Points - Wuhan Heyuan Biotechnology Co., Ltd. has approved the use of raised funds to replace self-raised funds previously invested in fundraising projects and to cover issuance expenses [2][6] - The total amount of raised funds is approximately RMB 2.6 billion, with a net amount of approximately RMB 2.43 billion after deducting issuance expenses [12][2] - The company plans to use RMB 469.56 million to replace self-raised funds for investment projects and RMB 5.19 million for issuance expenses [4][5] Fundraising Overview - The company issued 89,451,354 shares at a price of RMB 29.06 per share, raising a total of RMB 2,599,456,347.24 [12][2] - After deducting issuance expenses of RMB 169,031,770.68, the net amount raised is RMB 2,430,424,576.56 [12][2] - All raised funds are managed in a special account, with a tripartite supervision agreement in place [3] Investment Project Details - The company has pre-invested RMB 469,556,343.17 in fundraising projects using self-raised funds [4] - The issuance expenses totaled RMB 169,031,770.68, with RMB 5,187,028.30 already paid from self-raised funds [5] Approval Process - The board of directors approved the use of raised funds for replacement at a meeting held on November 21, 2025 [6] - The replacement of funds is compliant with relevant regulations and does not require shareholder approval [6][7] Cash Management Plan - The company plans to manage temporarily idle raised funds (including oversubscription funds) to enhance fund utilization efficiency [9][10] - The cash management will involve purchasing safe, liquid, principal-protected products, with a limit of RMB 2.1 billion [13][10] - The cash management period is valid for 12 months from the board's approval date [13][14] Risk Management - The company will select reputable financial institutions for cash management products and will monitor investment risks closely [19][20] - Independent directors and the audit committee will oversee the use of funds [20][21] Impact on Company Operations - The cash management initiative is designed to improve fund efficiency without affecting ongoing investment projects [23] - The company aims to generate additional returns for itself and its shareholders through this cash management strategy [23][25]

Core Points - The company has completed the cancellation of certain special accounts for raised funds, which were established for the management and use of funds from its initial public offering (IPO) [1][5] - The total amount raised from the IPO was RMB 920.304 million, with a net amount of RMB 811.342 million after deducting issuance costs [1][2] - The company has established a fund management system to ensure the proper storage and usage of the raised funds, in compliance with relevant laws and regulations [3] Fund Management and Usage - The company has set up special accounts for the raised funds in accordance with the "Company Law" and "Securities Law" of the People's Republic of China, as well as the regulations of the Shanghai Stock Exchange [3] - A tripartite or quadripartite supervision agreement was signed with the banks and the sponsor institution to clarify the rights and obligations of all parties involved in the management of the raised funds [3] - The company has transferred excess raised funds (including interest income) from one bank to another and subsequently decided to cancel the special account at the original bank [4][5]

Core Viewpoint - The company has approved the continued use of raised funds to purchase financial products or structured deposits, aiming to enhance fund utilization efficiency while ensuring that it does not affect the construction of investment projects or the use of raised funds [2][14]. Summary by Sections Fundraising Overview - The company raised a total of 1,315,319,983.02 RMB through a non-public offering of 115,076,114 shares at a price of 11.43 RMB per share, with a net amount of 1,303,670,100.75 RMB after deducting various fees [2][4]. Fund Management - The company has established a special account for the management and storage of raised funds, ensuring that all funds are deposited in a board-approved special account and are subject to regulatory agreements with the sponsoring institution and the commercial bank [3]. Investment Projects - The company has adjusted its investment projects, reallocating funds from the "Health Industry Expansion Project" to invest 45,800.58 million RMB in the "Traditional Chinese Medicine Production Base Construction Project" [5]. Cash Management - The company plans to use up to 850 million RMB of idle raised funds for purchasing safe, liquid financial products or structured deposits with a capital preservation commitment, with the authority to make investment decisions granted to the chairman or CFO [10][14]. Risk Control Measures - The company will select financial products from issuers that can provide capital preservation guarantees, ensuring high safety and liquidity, and will not affect the normal operation of the investment projects [15][17]. Approval Process - The decision to continue using idle raised funds for financial products was approved by the board's audit committee and the board of directors, confirming compliance with relevant regulations and ensuring that it aligns with the interests of the company and its shareholders [13][18].

Group 1 - The company completed the cancellation of its fundraising special account as part of its financial management strategy [4] - The company raised a total of RMB 383,714,880.00 through a non-public offering of 88,008,000 shares at RMB 4.36 per share, with a net amount of RMB 376,615,860.47 after deducting fees [2][3] - The company established a special account for the management of the raised funds, in compliance with relevant laws and regulations [2][3] Group 2 - The company approved the conclusion of several fundraising projects and decided to permanently supplement its working capital with the remaining funds [3][4] - The special account for the "Beihai Chengde Nickel Industry 132+180 Sintering Denitrification EPC Project" has been closed, and the remaining funds were transferred to the company's own account [4] - The agreements related to the special account management with the sponsor and banks have been terminated following the account closure [4]